Gerhard Domagk

Also found in: Dictionary, Medical, Wikipedia.

Domagk, Gerhard

(gĕr`härt dō`mäk), 1895–1964, German chemist and pathologist. A teacher successively at the universities of Greifswald and Münster, he became (1927) director of research at the I. G. Farbenindustrie laboratory at Wuppertal. Because of a Nazi decree he was obliged to decline the 1939 Nobel Prize in Physiology or Medicine. In 1947 he received a gold medal in lieu of the prize money. The award was made for his discovery of the efficacy of prontosil, the forerunner of the sulfa drugs, in treating streptococcal infections.

Domagk, Gerhard


Born Oct. 30, 1895, in Lagow, Brandenburg; died Apr. 24, 1964, in Kónigsfeld, Schwartzwald. German pathologist and microbiologist.

Domagk graduated in 1921 from the medical school of the University of Kiel. He became a professor of general pathology and pathological anatomy in Münster in 1928. In 1932 he began work on the chemotherapy of bacterial infections. He lived in the Federal Republic of Germany after 1949. In 1934, Domagk created domigon (an acridine derivative), the first effective drug for the treatment of gonorrhea, and introduced compounds of the sulfanilamide group to the treatment of many infectious diseases. He also developed a number of compounds for the chemotherapy of tuberculosis and tumors. Domagk was awarded the Nobel Prize in 1939.


Pathologische Anatomie und Chemotherapie der Infektsionskrankheiten. Stuttgart, 1947. (Bibliography.)
References in periodicals archive ?
The saga begins with Gerhard Domagk, who as a field physician for the German army in World War I witnessed soldiers' deaths and then dedicated his life to finding a way to protect other soldiers against the ravages of bacteria.
The German biochemist Gerhard Domagk (1895-1964) conducted systematic tests of new dyes synthesized since the time of Ehrlich to see if he could find something appropriate.